Cited by 166Genetic Neurodegenerative DiseasesNeuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Synaptic dysfunction in Huntington's disease: a new perspective

Open access

Smith, R., Brundin, P., Li, J.-Y.·2005·Cellular and Molecular Life Sciences

DOI 10.1007/s00018-005-5084-5PMC PMC11139070

Open this paper in CoChat — free account

Abstract

Huntington's disease (HD) is caused by a polyglutamine expansion in the protein huntingtin and is characterized by intraneuronal inclusions and widespread neuronal death at the late stage of the disease. In research, most of the emphasis has been on understanding the cell death and its mechanisms. Until recently, it was believed that the vast majority, if not all, of the symptoms in HD are a direct consequence of neurodegeneration. However, increasing evidence shows that subtle alterations in synaptic function could underlie the early symptoms. It is of particular interest to understand the nature of this neuronal dysfunction. Normal huntingtin interacts with various cytoskeletal and synaptic vesicle proteins that are essential for exocytosis and endocytosis. Altered interactions of mutant huntingtin with its associated partners could contribute to abnormal synaptic transmission in HD. This review describes recent advances in understanding synaptic dysfunction in HD.

Integrity signals

Registry

Crossref · 10.1007/s00018-005-5084-5

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein
Hartl, F. U., & Hayer-Hartl, M. K. (2002) · Science · doi:10.1126/science.1068408 · Cited by 3,335
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions
Saudou, F., Finkbeiner, S. M., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,598
Synaptic Vesicle Phosphoproteins and Regulation of Synaptic Function
Greengard, P., Valtorta, F., Czernik, A. J., & Benfenati, F. (1993) · Science · doi:10.1126/science.8430330 · Cited by 1,311
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity
Nucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J. C., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,112
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
Steffan, J. S., Kazantsev, A. G., Spasić-Bošković, O., Greenwald, M., Zhu, Y., Goehler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,057
Chaperone-Mediated Protein Folding
Fink, A. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.425 · Cited by 1,055
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A. J., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 1,000
Self-citation
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
Nasir, J., Floresco, S., OʼKusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A. H., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 878
A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration
Hodgson, J., Agopyan, N., Gutekunst, C., Leavitt, B. R., LePiane, F. G., Singaraja, R. R., Smith, D. J., Bissada, N., McCutcheon, K. M., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 851
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 821
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin [published erratum appears in Hum Mol Genet 1999 May;8(5):943]
Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 772
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi‐Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 723
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A. M., Kim, Y., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila
Gunawardena, S., Her, L.-S., Brusch, R. G., Laymon, R. A., Niesman, I. R., Gordesky-Gold, B., Sintasath, L., Bonini, N. M., & Goldstein, L. S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00594-4 · Cited by 665
Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation
Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lüder, G., Lehrach, H., & Wanker, E. E. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1393 · Cited by 637
Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
A huntingtin-associated protein enriched in brain with implications for pathology
Li, X., Li, S.-H., Sharp, A. H., Nucifora, F. C., Schilling, G., Lanahan, A. A., Worley, P. F., Snyder, S. H., & Ross, C. A. (1995) · Nature · doi:10.1038/378398a0 · Cited by 605
Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 600
Self-citation
Competitive binding of α-actinin and calmodulin to the NMDA receptor
Wyszynski, M., Lin, J., Rao, A., Nigh, E., Beggs, A. H., Craig, A. M., & Sheng, M. (1997) · Nature · doi:10.1038/385439a0 · Cited by 596
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
Dragatsis, I., Levine, M. S., & Zeitlin, S. O. (2000) · Nature Genetics · doi:10.1038/81593 · Cited by 580
Huntingtin–protein interactions and the pathogenesis of Huntington's disease
Li, S.-H., & Li, X. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.01.008 · Cited by 566
Snares and Munc18 in synaptic vesicle fusion
Rizo, J., & Südhof, T. C. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn898 · Cited by 539
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 535
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
Trushina, E., Dyer, R. B., Badger, J. D., Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8195-8209.2004 · Cited by 520
Mechanisms of Synaptic Vesicle Exocytosis
Lin, R. C.-S., & Scheller, R. H. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.19 · Cited by 512
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D. F., & Hannan, A. (2000) · Nature · doi:10.1038/35008142 · Cited by 499
Huntingtin and the molecular pathogenesis of Huntington's disease
Landles, C., & Bates, G. P. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400250 · Cited by 496
Dynactin, a conserved, ubiquitously expressed component of an activator of vesicle motility mediated by cytoplasmic dynein.
Gill, S. R., Schroer, T. A., Szilak, I., Steuer, E. R., Sheetz, M. P., & Cleveland, D. W. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.6.1639 · Cited by 487
Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1
Tang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Борисович, Б. И. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 487
Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions
Lunkes, A., Lindenberg, K. S., Ben-Haı̈em, L., Weber, C., Devys, D., Landwehrmeyer, G. B., Mandel, J., & Trottier, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00602-0 · Cited by 413
Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3
Rigamonti, D., Bauer, J. H., De‐Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A. S., Hayden, M. R., Li, Y., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03705.2000 · Cited by 406
Identification of potential target genes for the neuron-restrictive silencer factor.
Schoenherr, C. J., Paquette, A. J., & Anderson, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9881 · Cited by 406
Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
Reddy, P. H., Williams, M., Charles, V., Garrett, L. J., Pike-Buchanan, L., Whetsell, W. O., Miller, G., & Tagle, D. A. (1998) · Nature Genetics · doi:10.1038/2510 · Cited by 399
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain
Kalchman, M. A., Koide, H., McCutcheon, K. M., Graham, R. K., Nichol, K., Nishiyama, K., Kazemi‐Esfarjani, P., Lynn, F. C., Wellington, C. L., Metzler, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-44 · Cited by 378
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
Luthi‐Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1911 · Cited by 364
Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
Wyttenbach, A., Carmichael, J., Swartz, J., Furlong, R. A., Narain, Y., Rankin, J., & Rubinsztein, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2898 · Cited by 362
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J. M., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G. P., Cooper, J. A. D., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1 · Cited by 353
Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin
Engelender, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2205 · Cited by 344
Interaction of Huntington Disease Protein with Transcriptional Activator Sp1
Li, S.-H., Cheng, A. L., Zhou, H., Lam, S., Rao, M., He, L., & Li, X. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1277-1287.2002 · Cited by 343
Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport
Szebenyi, G., Morfini, G. A., Babcock, A., Gould, M., Selkoe, K. A., Stenoien, D. L., Young, M., Faber, P. W., MacDonald, M. E., McPhaul, M. J., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00569-5 · Cited by 326
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 322
Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasić-Bošković, O., Samuel, D., Goff, L. K., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 315
Cellular and molecular mechanisms of presynaptic assembly
Ziv, N. E., & Garner, C. C. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1370 · Cited by 312
Mouse models of Huntington's disease
Menalled, L., & Chesselet, M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 311
Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.
Gutekunst, C., Levey, A. I., Heilman, C. J., Whaley, W. L., Yi, H. L., Nash, N. R., Rees, H. D., Madden, J. J., & Hersch, S. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8710 · Cited by 305
Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A. C., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 291
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
Wyttenbach, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1829 · Cited by 274
Interaction of Huntingtin-Associated Protein with Dynactin P150Glued
Li, S., Gutekunst, C., Hersch, S. M., & Li, X.-J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01261.1998 · Cited by 271
Orexin loss in Huntington's disease
Petersén, Å., Gil‐Mohapel, J., Maat–Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R. A., Popović, N., Wierup, N., Norlén, P., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi004 · Cited by 269
Self-citation
HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system
Wanker, E. E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J., & Lehrach, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.487 · Cited by 260
Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways
Velier, J., Kim, M., Schwarz, C., Kim, T. W., Sapp, E., Chase, K., Aronin, N., & DiFiglia, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6832 · Cited by 258
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
Bogdanov, M., Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00689.x · Cited by 248
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
Cha, J.-H. J., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., Penney, J. B., Davies, S. W., Bates, G. P., & Young, A. B. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0449 · Cited by 239
Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntingtonʼs Disease—An In Situ Hybridization Study
Arzberger, T., Krampfl, K., Leimgruber, S., & Weindl, A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199704000-00013 · Cited by 233
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Self-citation
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles
Hilditch-Maguire, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2789 · Cited by 226
Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates
Donaldson, K. M., Li, W., Ching, K. A., Batalov, S., Tsai, C., & Joazeiro, C. A. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530212100 · Cited by 225
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
Sipione, S., Rigamonti, D., Valenza, M., Zuccato, C., Conti, L., Pritchard, J., Kooperberg, C. L., Olson, J. M., & Cattaneo, E. F. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu539 · Cited by 222
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis
Singaraja, R. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2815 · Cited by 222
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity
Sakahira, H., Breuer, P., Hayer-Hartl, M. K., & Hartl, F. U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182426899 · Cited by 220
SH3GL3 Associates with the Huntingtin Exon 1 Protein and Promotes the Formation of Polygln-Containing Protein Aggregates
Sittler, A., Wälter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G. P., Lehrach, H., & Wanker, E. E. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80142-2 · Cited by 218
An Actin-Binding Protein of the Sla2/Huntingtin Interacting Protein 1 Family Is a Novel Component of Clathrin-Coated Pits and Vesicles
Engqvist-Goldstein, Å. E. Y., Kessels, M. M., Chopra, V. S., Hayden, M. R., & Drubin, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1503 · Cited by 213
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects
Luthi‐Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1927 · Cited by 211
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
Petersén, Å. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1243 · Cited by 210
Huntington's disease: a synaptopathy?
Li, J., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208
Self-citation
Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production
Guidetti, P., Charles, V., Chen, E., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R. M., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 197
Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction
Qin, Z., Wang, Y., Sapp, E., Cuiffo, B., Wanker, E. E., Hayden, M. R., Kegel, K. B., D, N. A. M., & DiFiglia, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1409-03.2004 · Cited by 185
Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with β-tubulin: relevance to Huntington's disease
Hoffner, G., Kahlem, P., & Djian, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.941 · Cited by 182
The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human
Gutekunst, C., Li, S.-H., Yi, H. L., Ferrante, R. J., Li, X., & Hersch, S. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07674.1998 · Cited by 181
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntingtonʼs Disease
Kremer, H. P. H., Roos, R. A. C., Dingjan, G. M., Bots, G. T. A. M., & Maran, E. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199007000-00002 · Cited by 173
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 154
Self-citation
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient β-cell mass and exocytosis
Björkqvist, M., Fex, M., Renström, E., Wierup, N., Petersén, Å., Gil‐Mohapel, J., Bacos, K., Popović, N., Li, J., Sundler, F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi053 · Cited by 143
Self-citation
Synapsin I is a microtubule-bundling protein
Baines, A. J., & Bennett, V. (1986) · Nature · doi:10.1038/319145a0 · Cited by 142
Decreased cAMP Response Element-mediated Transcription
Sugars, K. L., Brown, R. L., Cook, L. J., Swartz, J., & Rubinsztein, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310226200 · Cited by 139
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
Chan, E. Y. W. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1939 · Cited by 138
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains
Modregger, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2547 · Cited by 138
Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Li, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg218 · Cited by 136
Evidence That the Rab3a-binding Protein, Rabphilin3a, Enhances Regulated Secretion.
Chung, S.-H., Takai, Y., & Holz, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16714 · Cited by 134
Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease
Morton, A. J., Faull, R. L. M., & Edwardson, J. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00611-6 · Cited by 132
Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression
Andreassen, O. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0562 · Cited by 123
The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease
Kremer, H. P. H., Roos, R. A. C., Dingjan, G. M., Bots, G. T. A. M., Bruyn, G. W., & Hofman, M. A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90443-w · Cited by 121
N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntingtonʼs disease mice
van Dellen, A., Welch, J., Dixon, R. M., Cordery, P. M., York, D. F., Styles, P., Blakemore, C. B., & Hannan, A. J. (2000) · Neuroreport · doi:10.1097/00001756-200011270-00032 · Cited by 121
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
Yu, Z.-X. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.8.905 · Cited by 121
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease
Hickey, M. A., Reynolds, G. P., & Morton, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00804.x · Cited by 117
Physical and Functional Interaction of Rabphilin-3A with α-Actinin
Kato, M., Sasaki, T., Ohya, T., Nakanishi, H., Nishioka, H., Imamura, M., & Takai, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31775 · Cited by 113
Complexin II is essential for normal neurological function in mice
Glynn, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg249 · Cited by 108
Enhanced Striatal NR2B-Containing N -Methyl- d -Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease
Li, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00308.2004 · Cited by 106
HIP1 and HIP12 Display Differential Binding to F-actin, AP2, and Clathrin
Legendre, V., Metzler, M., Charbonneau, M., Gan, L., Chopra, V. S., Philie, J., Hayden, M. R., & McPherson, P. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112310200 · Cited by 106
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation
Luthi-Carter, R., Apostol, B. L., Dunah, A. W., DeJohn, M. M., Farrell, L. A., Bates, G. P., Young, A. B., Standaert, D. G., Thompson, L. M., & Cha, J.-H. J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.024 · Cited by 104
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1
Zucker, B., Luthi‐Carter, R., Kama, J. A., Dunah, A. W., Stern, E. A., Fox, J. H., Standaert, D. G., Young, A. B., & Augood, S. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi014 · Cited by 99
CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice
Obrietan, K. H., & Hoyt, K. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3493-03.2004 · Cited by 98
Huntingtin-associated Protein 1 Interacts with Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate and Functions in Endosomal Trafficking
Li, Y., Chin, L., Levey, A. I., & Li, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111612200 · Cited by 98
Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation.
Pérez-Severiano, F., Escalante, B., Vergara, P., Ríos, C., & Segovia, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03102-5 · Cited by 95
Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation
Reynolds, G. P., Dalton, C., Tillery, C. E., Mangiarini, L., Davies, S. W., & Bates, G. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721773.x · Cited by 95
Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease
Morton, A. J., & Edwardson, J. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00059.x · Cited by 94
Identification of ubiquitin‐interacting proteins in purified polyglutamine aggregates
Doi, H., Mitsui, K., Kurosawa, M., Machida, Y., Kuroiwa, Y., & Nukina, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.077 · Cited by 93
Striatal neurochemical changes in transgenic models of Huntington's disease
Ariano, M. A., D, N. A. M., DiFiglia, M., Tagle, D. A., Sibley, D. R., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10272 · Cited by 91
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
Petersén, Å., Puschban, Z., Lotharius, J., NicNiocaill, B., Wiekop, P., O'Connor, W. T., & Brundin, P. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0534 · Cited by 90
Self-citation
Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice
NicNiocaill, B., Haraldsson, B., Hansson, O., O'Connor, W. T., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01379.x · Cited by 90
Self-citation
Molecular mechanisms of neurotransmitter release
Fon, E. A., & Edwards, R. H. (2001) · Muscle & Nerve · doi:10.1002/mus.1044 · Cited by 89
Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons
Goffredo, D., Rigamonti, D., Tartari, M., Micheli, A. D., Verderio, C., Matteoli, M., Zuccato, C., & Cattaneo, E. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200353200 · Cited by 86
Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model
Jarabek, B. R. (2003) · Brain · doi:10.1093/brain/awh058 · Cited by 82
Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
Singhrao, S., Thomas, P., Wood, J. D., Macmillan, J., Neal, J. W., Harper, P. S., & Jones, A. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6778 · Cited by 81
KIAA0369, doublecortin-like kinase, is expressed during brain development
Burgess, H. A., Martı́nez, S., & Reiner, O. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4 · Cited by 79
Abnormal Phosphorylation of Synapsin I Predicts a Neuronal Transmission Impairment in the R6/2 Huntington's Disease Transgenic Mice
Liévens, J.-C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1152 · Cited by 78
Characterization of Endophilin B1b, a Brain-specific Membrane-associated Lysophosphatidic Acid Acyl Transferase with Properties Distinct from Endophilin A1
Modregger, J., Schmidt, A., Ritter, B., Huttner, W. Β., & Plomann, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208568200 · Cited by 71
Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington’s disease transgenic mice
Deckel, A. W., Tang, V., Nuttal, D., Gary, K. A., & Elder, R. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02550-7 · Cited by 65
Comparative Analysis of Superoxide Dismutase Activity between Acute Pharmacological Models and a Transgenic Mouse Model of Huntington's Disease
Santamarı́a, A., Pérez‐Severiano, F., Rodrı́guez-Martı́nez, E., Maldonado, P. D., Pedraza‐Chaverrí, J., Rı́os, C., & Segovia, J. (2001) · Neurochemical Research · doi:10.1023/a:1010911417383 · Cited by 64
Expression of N-Methyl-D-Aspartate receptor subunit mRNAs in the human brain: Striatum and globus pallidus
Kosinski, C. M., Standaert, D. G., Counihan, T. J., Scherzer, C. R., Kerner, J. A., Daggett, L. P., Veli�elebi, G., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980105)390:1 · Cited by 62
Partial resistance to malonate‐induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length
Hansson, O., Castilho, R. F., Korhonen, L., Lindholm, D., Bates, G. P., & Brundin, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00482.x · Cited by 58
Self-citation
Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II
Edwardson, J. M., Wang, C., Gong, B., Wyttenbach, A., Bai, J., Jackson, M. B., Chapman, E. R., & Morton, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304615200 · Cited by 52
Maintenance of Susceptibility to Neurodegeneration Following Intrastriatal Injections of Quinolinic Acid in a New Transgenic Mouse Model of Huntington's Disease
Petersén, Å., Chase, K. O., Puschban, Z., DiFiglia, M., Brundin, P., & D, N. A. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7885 · Cited by 50
Self-citation
Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of l-NAME on symptom progression
Deckel, A. W., Gordinier, A., Nuttal, D., Tang, V., Kuwada, C. A., Freitas, R., & Gary, K. A. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03000-1 · Cited by 49
Cysteine String Protein (CSP) Inhibition of N-type Calcium Channels Is Blocked by Mutant Huntingtin
Miller, L. C., Swayne, L. A., Chen, L., Feng, Z., Wacker, J. L., Muchowski, P. J., Zamponi, G. W., & Braun, J. E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306230200 · Cited by 49
Inclusion formation in Huntington's disease R6/2 mouse muscle cultures
Orth, M., Cooper, J. A. D., Bates, G. P., & Schapira, A. H. V. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02009.x · Cited by 49
Inhibition of tryptophan hydroxylase activity and decreased 5‐HT1A receptor binding in a mouse model of Huntington's disease
Yohrling, G. J., Jiang, G. C. ‐., DeJohn, M. M., Robertson, D. J., Vrana, K. E., & Cha, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01084.x · Cited by 46
Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats
Hebb, M. O., Denovan‐Wright, E. M., & Robertson, H. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1099 · Cited by 41
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction
Smith, R. A., Petersén, Å., Bates, G. P., Brundin, P., & Li, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.008 · Cited by 38
Self-citation
Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions
Bates, G. P., & Davies, S. W. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01142-8 · Cited by 32
Genetically confirmed clinical Huntington's disease with no observable cell loss
Caramins, M. C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.968 · Cited by 32
An autopsy case with clinically and molecular genetically diagnosed Huntington's disease with only minimal non-specific neuropathological findings.
Mizuno, H., Shibayama, H., Tanaka, F., Doyu, M., Sobue, G., Iwata, H., Kobayashi, H., Yamada, K., Iwai, K., Takeuchi, T., et al. (2000) · PubMed · Cited by 29
Immediate‐early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice
MacGibbon, G. A., Hamilton, L. C., Crocker, S. F., Costain, W. J., Murphy, K. M., Robertson, H. A., & Denovan‐Wright, E. M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10100 · Cited by 23

Sorted by citations

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E. F., Zuccato, C., & Tartari, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1806 · Cited by 655
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
Sheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 593
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., Kurkinen, K. M. A., Yu, S., Savitt, J. M., Waldvogel, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21019 · Cited by 530
Mechanisms of neurodegeneration in Huntington’s disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 497

See all 166

Authors: Smith, R., Brundin, P., & Li, J.-Y.
Affiliations: Lund University (SE)
Corresponding author: Li, J.-Y.
ORCID: Smith, R.
Brundin, P.
Li, J.-Y.
Venue: Cellular and Molecular Life Sciences
Publisher: Springer Science and Business Media LLC
Published: 2005-06-15
Volume: 62
Issue: 17
Pages: 1901-1912
ISSN: 1420-682X (ISSN-L)
1420-9071
DOI: 10.1007/s00018-005-5084-5
PMC: PMC11139070
OpenAlex: W2132164151
Cited by: 166
References: 132
Citations by year: 2026: 2 · 2025: 3 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 10 · 2017: 8 · 2016: 10 · 2015: 4 · 2014: 10 · 2013: 10 · 2012: 12
FWCI: 3.87
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Cellular and Molecular Life Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, synaptic dysfunction, huntingtin, polyglutamine expansion, mutant huntingtin, synaptic vesicle proteins, exocytosis, endocytosis, synaptic transmission, neurodegeneration, neuronal dysfunction
MeSH terms: Huntingtin Protein, Animals, Brain, Exocytosis, Humans, Huntington Disease, Mutation, Nerve Tissue Proteins, Synaptic Transmission, Nuclear Proteins, Synapses, Transcription, Genetic, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Synaptic dysfunction in Huntington's disease: a new perspective

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks